131 related articles for article (PubMed ID: 14592539)
1. Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain.
Pascual I; Gil-Parrado S; Cisneros M; Joseph-Bravo P; Díaz J; Possani LD; Charli JL; Chávez M
Int J Biochem Cell Biol; 2004 Jan; 36(1):138-52. PubMed ID: 14592539
[TBL] [Abstract][Full Text] [Related]
2. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling and site-directed mutagenesis of pyroglutamyl peptidase II. Insights into omega-versus aminopeptidase specificity in the M1 family.
Chávez-Gutiérrez L; Matta-Camacho E; Osuna J; Horjales E; Joseph-Bravo P; Maigret B; Charli JL
J Biol Chem; 2006 Jul; 281(27):18581-90. PubMed ID: 16611635
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis.
Angel Vargas M; Uribe RM; Cisneros M; Romero F; González S; Joseph-Bravo P; Charli JL
Eur J Endocrinol; 2002 Sep; 147(3):363-9. PubMed ID: 12213674
[TBL] [Abstract][Full Text] [Related]
5. A truncated isoform of pyroglutamyl aminopeptidase II produced by exon extension has dominant-negative activity.
Chávez-Gutiérrez L; Bourdais J; Aranda G; Vargas MA; Matta-Camacho E; Ducancel F; Segovia L; Joseph-Bravo P; Charli JL
J Neurochem; 2005 Feb; 92(4):807-17. PubMed ID: 15686482
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.
Vargas MA; Joseph-Bravo P; Charli JL
Neuroendocrinology; 1994 Sep; 60(3):323-30. PubMed ID: 7969791
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain.
Charli JL; Mendez M; Joseph-Bravo P; Wilk S
Neuropeptides; 1987; 9(4):373-8. PubMed ID: 2886950
[TBL] [Abstract][Full Text] [Related]
8. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
[TBL] [Abstract][Full Text] [Related]
9. Rapid down regulation of pyroglutamyl peptidase II activity by arachidonic acid in primary cultures of adenohypophyseal cells.
Baeza MA; Ponce G; Joseph-Bravo P; Charli JL
Life Sci; 2001 Mar; 68(17):2051-60. PubMed ID: 11388706
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone-induced down-regulation of pyroglutamyl aminopeptidase II activity involves L-type calcium channels and cam kinase activities in cultures of adenohypophyseal cells.
Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
J Neuroendocrinol; 2002 Mar; 14(3):184-93. PubMed ID: 11999717
[TBL] [Abstract][Full Text] [Related]
11. Pyroglutamyl peptidase II activity is not in the processes of bulbospinal TRHergic neurons.
Joseph-Bravo P; Fresán M; Cisneros M; Vargas MA; Charli JL
Neurosci Lett; 1994 Sep; 178(2):243-6. PubMed ID: 7824205
[TBL] [Abstract][Full Text] [Related]
12. Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release.
Cruz R; Vargas MA; Uribe RM; Pascual I; Lazcano I; Yiotakis A; Matziari M; Joseph-Bravo P; Charli JL
Peptides; 2008 Nov; 29(11):1953-64. PubMed ID: 18703099
[TBL] [Abstract][Full Text] [Related]
13. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
Wilk S; Friedman TC; Kline TB
Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
[TBL] [Abstract][Full Text] [Related]
14. Changes in TRH and its degrading enzyme pyroglutamyl peptidase II, during the development of amygdaloid kindling.
de Gortari P; Fernández-Guardiola A; Martinez A; Cisneros M; Joseph-Bravo P
Brain Res; 1995 May; 679(1):144-50. PubMed ID: 7648256
[TBL] [Abstract][Full Text] [Related]
15. NMDA receptor up-regulates pyroglutamyl peptidase II activity in the rat hippocampus.
Rodríguez-Molina V; Vargas MA; Joseph-Bravo P; Charli JL
Neurosci Lett; 2009 Jan; 449(3):211-4. PubMed ID: 19013213
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions.
de Gortari P; Cisneros M; Joseph-Bravo P
Regul Pept; 2005 Apr; 127(1-3):141-50. PubMed ID: 15680480
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
Browne P; O'Cuinn G
Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
[TBL] [Abstract][Full Text] [Related]
18. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway.
Vargas MA; Bourdais J; Sanchez S; Uriostegui B; Moreno E; Joseph-Bravo P; Charli JL
J Neuroendocrinol; 1998 Mar; 10(3):199-206. PubMed ID: 9576608
[TBL] [Abstract][Full Text] [Related]
19. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
Friedman TC; Wilk S
J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
[TBL] [Abstract][Full Text] [Related]
20. Fasting Enhances Pyroglutamyl Peptidase II Activity in Tanycytes of the Mediobasal Hypothalamus of Male Adult Rats.
Lazcano I; Cabral A; Uribe RM; Jaimes-Hoy L; Perello M; Joseph-Bravo P; Sánchez-Jaramillo E; Charli JL
Endocrinology; 2015 Jul; 156(7):2713-23. PubMed ID: 25942072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
